Pharmaniaga Bhd says despite recording its largest quarterly net loss of RM664.39 million, its quarterly revenue grew 21.2% to RM862.72 million. – The Malaysian Insight file pic, February 27, 2023.
GOVERNMENT-linked pharmaceutical company Pharmaniaga Bhd has been issued the Practice Note 17 after it was labelled financially distressed on Bursa Malaysia. Its directors said the PN17 was triggered in the company’s audited consolidated financial statements for the period until December 31, 2022. Effective July 2018, access to full reports will only be available with a subscription. Sign-up now and enjoy one week free access!
It has all in 15 senior mgmt consisting of various Chief of..something & President of something, yet it failed absolutely miserably, even with 'big tongkat' from the Gov. Pls replace everyone each of them incld.the BOD. Useless money bleeding agency ! pakatanharapan_
PN MPs dont want to talk about this issue at parliament? 🤔
How on God’s green earth did they do that? They cannot lose but yet…. Just truly Unbelievable. Monopoly also useless.